36mon MSN
Some supplements may reduce cancer risk or provide symptom relief, while others can increase risks or interfere with treatments.
Increasing numbers of women are getting additional screenings to rule out breast cancer. But such screenings cost money, out ...
6h
GlobalData on MSNFDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancerThe US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
Several key members of the Senate Finance Committee have reintroduced a bill that seeks to establish a Medicare coverage ...
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
The Associated Press on MSN9d
Red dye No. 3 has been banned, but what about other artificial food dyes?The Food and Drug Administration said it was taking the action because studies found that the dye, also known as erythrosine, ...
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast cancer study and altering patient records after her authorization was revoked ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
After a momentous 2024, Culver City-based ImmunityBio Inc., the immunotherapy company founded and majority-owned by ...
The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results